Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Emilio, García Cabrera"'
Autor:
Daniel Raposo Puglia, José Ángel Raposo Puglia, Emilio García-Cabrera, Fátima Morales, Juan Carlos Camacho-Vega, Ángel Vilches-Arenas
Publikováno v:
Clinics and Practice, Vol 14, Iss 1, Pp 280-292 (2024)
(1) Background: Aspergillus spp. is a widely distributed filamentous fungus in the environment due to its high sporulation capacity. Currently, invasive aspergillosis (IA) is the most common invasive fungal infection in patients with hematologic mali
Externí odkaz:
https://doaj.org/article/a8f11ed1142649389c954b3b5e6ad1d2
Autor:
Elena Prado-Mel, Héctor Rodríguez Ramallo, Ángela María Villalba-Moreno, Emilio García Cabrera, Susana Sánchez-Fidalgo
Publikováno v:
Pharmaceutical Care España, Vol 26 (2024)
Objetivo: analizar las características demográficas, clínicas y funcionales de personas residentes en un centro sociosanitario público. Caracterizar a la población en función del riesgo anticolinérgico según la escala DBI. Metodología: estud
Externí odkaz:
https://doaj.org/article/fe58c5e1c5a543e1b170b06c555545b7
Autor:
Marta Mejías-Trueba, Aitana Rodríguez-Pérez, Emilio García-Cabrera, Carlos Jiménez-Juan, Susana Sánchez-Fidalgo
Publikováno v:
Healthcare, Vol 11, Iss 13, p 1879 (2023)
Background and objective: There are barriers to deprescription that hinder its implementation in clinical practice. The objective of this study was to analyse the main barriers and limitations of the deprescription process perceived by physicians who
Externí odkaz:
https://doaj.org/article/3e07cbee05984810a76df93a1400f560
Autor:
Javier Deira, Miguel A. Suárez, Francisca López, Emilio García-Cabrera, Antonio Gascón, Eduardo Torregrosa, Giannina E. García, Jorge Huertas, Jose C. de la Flor, Suleya Puello, Jonathan Gómez-Raja, Jesús Grande, José L. Lerma, Carlos Corradino, Carlos Musso, Manuel Ramos, Jesús Martín, Carlo Basile, Francesco G. Casino
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background Most people who make the transition to renal replacement therapy (RRT) are treated with a fixed dose thrice-weekly hemodialysis réegimen, without considering their residual kidney function (RKF). Recent papers inform us that incr
Externí odkaz:
https://doaj.org/article/06af19e98fbe4b0c9101b0220744fa3b
Autor:
Miguel A. Suárez, Emilio García-Cabrera, Antonio Gascón, Francisca López, Eduardo Torregrosa, Giannina E. García, Jorge Huertas, José C. de la Flor, Suleyka Puello, Jonathan Gómez-Raja, Jesús Grande, José L. Lerma, Carlos Corradino, Manuel Ramos, Jesús Martín, Carlo Basile, Francesco G. Casino, Javier Deira
Publikováno v:
Nefrología (English Edition), Vol 38, Iss 6, Pp 630-638 (2018)
Introduction: Progressive haemodialysis (HD) is a starting regime for renal replacement therapy (RRT) adapted to each patient's necessities. It is mainly conditioned by the residual renal function (RRF). The frequency of sessions with which patients
Externí odkaz:
https://doaj.org/article/50c542df360c414a870db7ba87a9e32f
Autor:
Miguel A. Suárez, Emilio García-Cabrera, Antonio Gascón, Francisca López, Eduardo Torregrosa, Giannina E. García, Jorge Huertas, José C. de la Flor, Suleyka Puello, Jonathan Gómez-Raja, Jesús Grande, José L. Lerma, Carlos Corradino, Manuel Ramos, Jesús Martín, Carlo Basile, Francesco G. Casino, Javier Deira
Publikováno v:
Nefrología, Vol 38, Iss 6, Pp 630-638 (2018)
Resumen: Introducción: La hemodiálisis (HD) progresiva es una modalidad de inicio del tratamiento renal sustitutivo adaptada a las necesidades individuales de cada paciente. Está condicionada fundamentalmente por la función renal residual (FRR).
Externí odkaz:
https://doaj.org/article/64487e79db514092a2d1a0e3de67afca
Autor:
Sánchez-Fidalgo, Marta Mejías-Trueba, Aitana Rodríguez-Pérez, Emilio García-Cabrera, Carlos Jiménez-Juan, Susana
Publikováno v:
Healthcare; Volume 11; Issue 13; Pages: 1879
Background and objective: There are barriers to deprescription that hinder its implementation in clinical practice. The objective of this study was to analyse the main barriers and limitations of the deprescription process perceived by physicians who
Publikováno v:
Cannabis and Cannabinoid Research.
Autor:
José Manuel Muñoz-Terol, José L. Rocha, Pablo Castro-de la Nuez, Juan José Egea-Guerrero, Luis Gil-Sacaluga, Emilio García-Cabrera, Angel Vilches-Arenas
Publikováno v:
Journal of Personalized Medicine; Volume 13; Issue 4; Pages: 605
Background: Survival in patients with end-stage kidney disease (ESKD) on renal replacement therapy (RRT) is less than that of the general population of the same age, and depends on patient factors, the medical care received, and the type of RRT used.
Autor:
José Manuel Muñoz-Terol, José L. Rocha, Pablo Castro-de la Nuez, Emilio García-Cabrera, Ángel Vilches-Arenas
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 1; Pages: 51
Background: Chronic kidney disease is the non-communicable disease with the highest growth in morbidity and mortality. Renal transplantation (RT) is the first option of renal replacement in end-stage kidney disease (ESKD) and dialysis is an alternati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ac80353b0d11747cccf1d2d820482e7